
FDA Releases Guidance on Communication with the Agency
The agency publishes draft guidance on best practices for communication between FDA and IND sponsors during drug development.
FDA released
The guidance does not apply to communications between FDA and industry trade organizations, consumer advocacy groups, other government agencies, or non-IND stakeholders. FDA states that the guidance will be updated as communication practices evolve.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.